Status:
RECRUITING
The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen
Lead Sponsor:
Wake Forest University Health Sciences
Conditions:
Acute Myelogenous Leukemia
Acute Lymphocytic Leukemia
Eligibility:
All Genders
18-120 years
Brief Summary
To provide the IRB approved mechanism for the prospective collection, analysis and reporting of data on patients who are undergoing either an autologous or allogeneic hematopoietic stem cell transplan...
Eligibility Criteria
Inclusion
- Planned standard of care dose intensive therapy and either an allogeneic or autologous bone marrow transplant
Exclusion
- Participation in any other treatment research protocol
Key Trial Info
Start Date :
May 21 2001
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
June 1 2026
Estimated Enrollment :
2000 Patients enrolled
Trial Details
Trial ID
NCT01890486
Start Date
May 21 2001
End Date
June 1 2026
Last Update
December 22 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Wake Forest Baptist Health
Winston-Salem, North Carolina, United States, 27157